secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001104659-26-023189
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elutia regains full compliance with Nasdaq minimum bid price and MVLS requirements
--------------------------------------------------------------------------------

- Received Nasdaq notice on March 2, 2026, confirming compliance with minimum bid price rule (bid ≥ $1.00 for 10 consecutive days).
- Received Nasdaq notice on February 5, 2026, confirming compliance with MVLS requirement (MVLS ≥ $35M for 11 consecutive days).
- All Nasdaq continued listing requirements are now met; matters are closed; stock continues trading on Nasdaq Capital Market under symbol ELUT.
- CFO Matt Ferguson cites investor confidence in drug-eluting biomatrix technology platform and market opportunity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465926023189/0001104659-26-023189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465926023189/elut-20260304x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-023189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer